118 related articles for article (PubMed ID: 9236922)
1. Incorporation of 5-fluorouracil into hepatoma and normal tissue RNA at protein depletion in the rat.
Roos G; Stenram U
J Surg Oncol; 1997 Jul; 65(3):155-8. PubMed ID: 9236922
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.
Jakobsson B; Roos G; el Hag IA; Jönsson PE; Stenram U
Res Exp Med (Berl); 1992; 192(1):13-21. PubMed ID: 1570410
[TBL] [Abstract][Full Text] [Related]
3. Relation between the incorporation of 5-fluorouracil into liver carcinoma and normal tissue RNA at hepatic arterial administration in the rat is altered by overnight starvation.
Roos G; Stenram U
J Surg Oncol; 1993 Aug; 53(4):231-4. PubMed ID: 7688058
[TBL] [Abstract][Full Text] [Related]
4. RNA labelling with 3H-orotic acid and 3H-fluorouracil of rat liver tumour following transient hepatic arterial ischaemia.
Mack P; Tranberg KG; Strenram U; Jeppsson B; Widlus D; Bengmark S
Eur J Surg Oncol; 1988 Dec; 14(6):669-75. PubMed ID: 3192004
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.
el Hag IA; Jakobsson B; Erichsen C; Christensson PI; Jönsson PE; Stenram U
In Vivo; 1987; 1(4):215-20. PubMed ID: 2485132
[TBL] [Abstract][Full Text] [Related]
6. Effects of dosage and infusion time on the incorporation of 5-fluorouracil into DNA and RNA of normal tissues and an adenocarcinoma transplanted to rat liver.
Erichsen C; Christensson PI; Jacobsson B; Jönsson PE; Stenram U
J Surg Oncol; 1988 Jul; 38(3):155-9. PubMed ID: 2455851
[TBL] [Abstract][Full Text] [Related]
7. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
Engelbrecht C; Ljungquist I; Lewan L; Yngner T
Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of the combined effect of 5-fluorouracil and cyclophosphane on growth of Zajdela hepatoma and nucleic acid metabolism].
Reztsova VV; Stukov AN; Filov VA
Biull Eksp Biol Med; 1980 Oct; 90(10):469-71. PubMed ID: 7426710
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil incorporation into RNA of a rat liver adenocarcinoma after hepatic artery injection together with degradable starch microspheres.
Teder H; Erichsen C; Christensson PI; Jönsson PE; Stenram U
Cancer Drug Deliv; 1987; 4(3):169-76. PubMed ID: 2453264
[TBL] [Abstract][Full Text] [Related]
10. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion in the treatment of liver metastases with PEG liposomes in combination with degradable starch microspheres (DSM) increases tumor 5-FU concentration. an animal study in CC-531 liver tumor-bearing rats.
Pohlen U; Reszka R; Buhr HJ; Berger G
Anticancer Res; 2011 Jan; 31(1):147-52. PubMed ID: 21273592
[TBL] [Abstract][Full Text] [Related]
12. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
[TBL] [Abstract][Full Text] [Related]
13. The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping.
el Hag IA; Jakobsson B; Jönsson PE; Stenram U
Res Exp Med (Berl); 1990; 190(3):183-92. PubMed ID: 1695018
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 5-fluorouracil in sensitive and resistant tumor cells.
Fukushima M; Ikenaka K; Shirasaka T; Fujii S
Gan; 1979 Feb; 70(1):47-53. PubMed ID: 556350
[TBL] [Abstract][Full Text] [Related]
15. Interferon and the incorporation of 5-fluorouracil into RNA of normal tissues and a secondary liver carcinoma in rat.
Roos G; Stenram U
Anticancer Res; 1994; 14(2A):379-82. PubMed ID: 7517119
[TBL] [Abstract][Full Text] [Related]
16. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model.
Sadahiro S; Suzuki T; Ishikawa K; Tanaka Y; Masuda T; Nakamura T; Yasuda S; Makuuchi H; Murayama C
Jpn J Clin Oncol; 2003 Aug; 33(8):377-81. PubMed ID: 14523056
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
Jakobsson B; el Hag IA; Erichsen C; Christensson PI; Jönsson PE; Stenram U
Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255
[TBL] [Abstract][Full Text] [Related]
19. Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
Hoshino S; Yamashita Y; Maekawa T; Shirakusa T
Cancer Chemother Pharmacol; 2005 Dec; 56(6):648-52. PubMed ID: 15959779
[TBL] [Abstract][Full Text] [Related]
20. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.
Cory JG; Breland JC; Carter GL
Cancer Res; 1979 Dec; 39(12):4905-13. PubMed ID: 498116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]